Ariela Samantha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ariela Samantha has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Alice Vrielink
The University of Western Australia
2 shared publications- Alice Vrielink
School of Chemistry and Biochemistry, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia
1 shared publication Caitlyn Christvania Sihombing
Universitas Pelita Harapan
1 shared publicationChristopher Hosking
Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Victoria, Australia; AdAlta Pty. Ltd, Bundoora, Victoria, Australia
1 shared publicationEmel Rothzerg
School of Biomedical Sciences, University of Western Australia, Perth, Western Australia, Australia
1 shared publicationHaiming Jin
Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication
Latest Publications
- 8 November 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (11)
Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer
Objective: This study aimed to investigate the expression pattern, clinical significance, immune association and biological function of general control nonderepressible 1 (GCN1) in colorectal cancer (CRC). Methods: Gene expression and clinical data from 1603 CRC patients were obtained from TCGA and E‐MTAB‐12862 datasets, with external validation using GEO cohorts. Tumour immune cell proportions were estimated using the CIBERSORT and ESTIMATE algorithms. Predicted drug responses were assessed using the oncoPredict package based on the GDSC database. In vitro functional experiments, including MTT proliferation assays and transwell migration and invasion assays, were conducted in HCT116 and HT29 cell lines following GCN1 knockdown. Results: GCN1 was significantly upregulated in CRC tissues compared with normal tissues. Higher GCN1 expression was associated with improved overall survival in early‐stage CRC and lower tumour stage. Immune microenvironment analysis revealed that tumours with high GCN1 expression showed computationally inferred enrichment of antitumor immune cell populations and reduced immunosuppressive components, along with lower TIDE scores. Functional enrichment analyses indicated that GCN1 was involved in pathways related to cell cycle regulation, DNA replication and epithelial–mesenchymal transition (EMT). Knockdown of GCN1 significantly inhibited CRC cell proliferation, migration and invasion while modulating EMT and cell cycle‐related proteins. Drug sensitivity prediction further indicated that tumours with high GCN1 expression exhibited lower computationally inferred IC50 values for several commonly used chemotherapeutic agents, including 5‐fluorouracil, oxaliplatin, paclitaxel and docetaxel. Conclusion: Our findings suggest that GCN1 may exhibit context‐dependent associations in CRC. While in vitro experiments support a tumour cell‐intrinsic role of GCN1 in regulating malignant phenotypes through EMT‐ and cell cycle‐related processes, higher GCN1 expression at the tissue level was also associated with favourable clinical and immune‐related features. These observations suggest that GCN1 may serve as a potential prognostic indicator and warrant further mechanistic investigation.
- 8 November 2026
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 53 (11)
Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer
Objective: This study aimed to investigate the expression pattern, clinical significance, immune association and biological function of general control nonderepressible 1 (GCN1) in colorectal cancer (CRC). Methods: Gene expression and clinical data from 1603 CRC patients were obtained from TCGA and E‐MTAB‐12862 datasets, with external validation using GEO cohorts. Tumour immune cell proportions were estimated using the CIBERSORT and ESTIMATE algorithms. Predicted drug responses were assessed using the oncoPredict package based on the GDSC database. In vitro functional experiments, including MTT proliferation assays and transwell migration and invasion assays, were conducted in HCT116 and HT29 cell lines following GCN1 knockdown. Results: GCN1 was significantly upregulated in CRC tissues compared with normal tissues. Higher GCN1 expression was associated with improved overall survival in early‐stage CRC and lower tumour stage. Immune microenvironment analysis revealed that tumours with high GCN1 expression showed computationally inferred enrichment of antitumor immune cell populations and reduced immunosuppressive components, along with lower TIDE scores. Functional enrichment analyses indicated that GCN1 was involved in pathways related to cell cycle regulation, DNA replication and epithelial–mesenchymal transition (EMT). Knockdown of GCN1 significantly inhibited CRC cell proliferation, migration and invasion while modulating EMT and cell cycle‐related proteins. Drug sensitivity prediction further indicated that tumours with high GCN1 expression exhibited lower computationally inferred IC50 values for several commonly used chemotherapeutic agents, including 5‐fluorouracil, oxaliplatin, paclitaxel and docetaxel. Conclusion: Our findings suggest that GCN1 may exhibit context‐dependent associations in CRC. While in vitro experiments support a tumour cell‐intrinsic role of GCN1 in regulating malignant phenotypes through EMT‐ and cell cycle‐related processes, higher GCN1 expression at the tissue level was also associated with favourable clinical and immune‐related features. These observations suggest that GCN1 may serve as a potential prognostic indicator and warrant further mechanistic investigation.
- Open Access
- 31 May 2024
- Published by Universitas Pelita Harapan in FaST - Jurnal Sains dan Teknologi (Journal of Science and Technology)
- Vol. 8 (1) , 91-105
STABILITY AND ACTIVITY OF LIPID A PHOSPHOETHANOLAMINE TRANSFERASE FROM NEISSERIA MENINGITIDIS IN THE PRESENCE OF SODIUM DEOXYCHOLATE [STABILITAS DAN AKTIVITAS LIPID A PHOSPHOETHANOLAMINE TRANSFERASE DARI NEISSERIA MENINGITIDIS TERHADAP PENAMBAHAN NATRIUM DEOKSIKOLAT]
Antibiotics are often used to fight infections caused by pathogenic bacteria. However, inappropriate use of antibiotics has caused many pathogenic bacteria to gain antibiotic resistance. Some resistance mechanisms arise through enzymatic modification of the bacterial membrane. Lipid A phosphoethanolamine transferase (EptA) modifies bacterial membranes through the addition of phosphoethanolamine to the lipid A moiety of lipopolysaccharide (LPS) or lipooligosaccharide (LOS). Inhibition of EptA would therefore restore the antibiotic susceptibility of the bacterium. In order to develop inhibitors against EptA, in vitro studies are required. Biochemical studies of membrane proteins such as EptA, must be carried out in buffers containing detergent to ensure the solubility and stability of the membrane protein. EptA has been found to be most stable in buffers containing the detergent, n-dodecyl β-D-maltoside (DDM). However, due to the fact that LOS is also required for biochemical studies of EptA, the detergent, sodium deoxycholate (DOC) is also required as it prevents the aggregation of LOS. In this study, the stability and activity of EptA in the presence of DOC were investigated using thin layer chromatography (TLC) and circular dichroism (CD) spectroscopy. Additionally, preliminary studies on the interaction of EptA and LOS in vitro was carried out using native agarose gel electrophoresis (NAGE). This study shows that EptA remains active in the presence of ‰¤ 2 mM DOC with the highest activity observed in buffers containing only 1 mM DOC. CD analysis showed that the overall secondary structure of EptA in buffer containing various concentrations of DDM and DOC was maintained. Additionally, through NAGE analysis the interaction between EptA and LOS was successfully observed. Therefore, further in vitro studies incorporating both substrates with supplementation of up to 1 mM DOC could be carried out with the long-term goal of studying inhibitors against EptA.Bahasa Indonesia Antibiotik sering digunakan untuk melawan infeksi yang disebabkan oleh bakteri patogen. Namun, penggunaan antibiotik yang tidak tepat telah menyebabkan banyak bakteri patogen mendapatkan resistensi antibiotik. Beberapa mekanisme resistensi muncul melalui modifikasi enzimatik dari membran bakteri. Lipid A phosphoethanolamine transferase (EptA) mengubah membran bakteri dengan menambahkan fosfoetanolamina ke bagian lipid A dari lipopolisakarida (LPS) atau lipooligosakarida (LOS). Penghambatan EptA akan mengembalikan kerentanan antibiotik dari bakteri tersebut. Untuk mengembangkan inhibitor terhadap EptA, studi in vitro diperlukan. Studi biokimia protein membran seperti EptA, harus dilakukan dalam larutan penyangga yang mengandung deterjen untuk memastikan kelarutan dan stabilitas protein membran. EptA ditemukan paling stabil dalam larutan penyangga yang mengandung deterjen, n-dodecyl β-D-maltosida (DDM). Namun, karena LOS juga diperlukan untuk studi biokimia EptA, deterjen, sodium deoksikolat (DOC) juga diperlukan karena mencegah agregasi LOS. Dalam penelitian ini, stabilitas dan aktivitas EptA dalam keberadaan DOC diselidiki menggunakan kromatografi lapis tipis (TLC) dan spektroskopi dikroisme sirkular (CD). Selain itu, studi awal tentang interaksi EptA dan LOS in vitro dilakukan menggunakan elektroforesis gel agarosa asli (NAGE). Studi ini menunjukkan bahwa EptA tetap aktif dalam keberadaan ‰¤ 2 mM DOC dengan aktivitas tertinggi diamati dalam larutan penyangga yang hanya mengandung 1 mM DOC. Analisis CD menunjukkan bahwa struktur sekunder keseluruhan EptA dalam larutan penyangga yang mengandung berbagai konsentrasi DDM dan DOC tetap terjaga. Selain itu, melalui analisis NAGE, interaksi antara EptA dan LOS berhasil diamati. Oleh karena itu, studi in vitro lebih lanjut yang memasukkan kedua substrat dengan suplementasi hingga 1 mM DOC bisa dilakukan dengan tujuan jangka panjang untuk mempelajari inhibitor terhadap EptA.
- 31 May 2024
- Published by Universitas Pelita Harapan in FaST - Jurnal Sains dan Teknologi (Journal of Science and Technology)
- Vol. 8 (1) , 91-105
Open AccessSTABILITY AND ACTIVITY OF LIPID A PHOSPHOETHANOLAMINE TRANSFERASE FROM NEISSERIA MENINGITIDIS IN THE PRESENCE OF SODIUM DEOXYCHOLATE [STABILITAS DAN AKTIVITAS LIPID A PHOSPHOETHANOLAMINE TRANSFERASE DARI NEISSERIA MENINGITIDIS TERHADAP PENAMBAHAN NATRIUM DEOKSIKOLAT]
Antibiotics are often used to fight infections caused by pathogenic bacteria. However, inappropriate use of antibiotics has caused many pathogenic bacteria to gain antibiotic resistance. Some resistance mechanisms arise through enzymatic modification of the bacterial membrane. Lipid A phosphoethanolamine transferase (EptA) modifies bacterial membranes through the addition of phosphoethanolamine to the lipid A moiety of lipopolysaccharide (LPS) or lipooligosaccharide (LOS). Inhibition of EptA would therefore restore the antibiotic susceptibility of the bacterium. In order to develop inhibitors against EptA, in vitro studies are required. Biochemical studies of membrane proteins such as EptA, must be carried out in buffers containing detergent to ensure the solubility and stability of the membrane protein. EptA has been found to be most stable in buffers containing the detergent, n-dodecyl β-D-maltoside (DDM). However, due to the fact that LOS is also required for biochemical studies of EptA, the detergent, sodium deoxycholate (DOC) is also required as it prevents the aggregation of LOS. In this study, the stability and activity of EptA in the presence of DOC were investigated using thin layer chromatography (TLC) and circular dichroism (CD) spectroscopy. Additionally, preliminary studies on the interaction of EptA and LOS in vitro was carried out using native agarose gel electrophoresis (NAGE). This study shows that EptA remains active in the presence of ‰¤ 2 mM DOC with the highest activity observed in buffers containing only 1 mM DOC. CD analysis showed that the overall secondary structure of EptA in buffer containing various concentrations of DDM and DOC was maintained. Additionally, through NAGE analysis the interaction between EptA and LOS was successfully observed. Therefore, further in vitro studies incorporating both substrates with supplementation of up to 1 mM DOC could be carried out with the long-term goal of studying inhibitors against EptA.Bahasa Indonesia Antibiotik sering digunakan untuk melawan infeksi yang disebabkan oleh bakteri patogen. Namun, penggunaan antibiotik yang tidak tepat telah menyebabkan banyak bakteri patogen mendapatkan resistensi antibiotik. Beberapa mekanisme resistensi muncul melalui modifikasi enzimatik dari membran bakteri. Lipid A phosphoethanolamine transferase (EptA) mengubah membran bakteri dengan menambahkan fosfoetanolamina ke bagian lipid A dari lipopolisakarida (LPS) atau lipooligosakarida (LOS). Penghambatan EptA akan mengembalikan kerentanan antibiotik dari bakteri tersebut. Untuk mengembangkan inhibitor terhadap EptA, studi in vitro diperlukan. Studi biokimia protein membran seperti EptA, harus dilakukan dalam larutan penyangga yang mengandung deterjen untuk memastikan kelarutan dan stabilitas protein membran. EptA ditemukan paling stabil dalam larutan penyangga yang mengandung deterjen, n-dodecyl β-D-maltosida (DDM). Namun, karena LOS juga diperlukan untuk studi biokimia EptA, deterjen, sodium deoksikolat (DOC) juga diperlukan karena mencegah agregasi LOS. Dalam penelitian ini, stabilitas dan aktivitas EptA dalam keberadaan DOC diselidiki menggunakan kromatografi lapis tipis (TLC) dan spektroskopi dikroisme sirkular (CD). Selain itu, studi awal tentang interaksi EptA dan LOS in vitro dilakukan menggunakan elektroforesis gel agarosa asli (NAGE). Studi ini menunjukkan bahwa EptA tetap aktif dalam keberadaan ‰¤ 2 mM DOC dengan aktivitas tertinggi diamati dalam larutan penyangga yang hanya mengandung 1 mM DOC. Analisis CD menunjukkan bahwa struktur sekunder keseluruhan EptA dalam larutan penyangga yang mengandung berbagai konsentrasi DDM dan DOC tetap terjaga. Selain itu, melalui analisis NAGE, interaksi antara EptA dan LOS berhasil diamati. Oleh karena itu, studi in vitro lebih lanjut yang memasukkan kedua substrat dengan suplementasi hingga 1 mM DOC bisa dilakukan dengan tujuan jangka panjang untuk mempelajari inhibitor terhadap EptA.
- Open Access
- 9 January 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (2) , 102889
ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
- 9 January 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (2) , 102889
Open AccessADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
- 1 August 2020
- Published by Elsevier in Journal of Molecular Biology
- Vol. 432 (18) , 5184-5196
Lipid A Phosphoethanolamine Transferase: Regulation, Structure and Immune Response
- 1 August 2020
- Published by Elsevier in Journal of Molecular Biology
- Vol. 432 (18) , 5184-5196
Lipid A Phosphoethanolamine Transferase: Regulation, Structure and Immune Response